Hodgkin's and non-Hodgkin's lymphomas are an important part of the differential diagnosis of head and neck tumors. Their diagnosis begins with a complete history and physical examination and is confirmed with an appropriately obtained and prepared pathologic specimen. Prognosis and therapy of the ...
Kaposi's sarcoma, non-Hodgkin's lymphoma, Hodgkin's disease, and squamous cell carcinoma are among the malignancies seen with increased frequency in patients infected with HIV. The outlook for patients with these malignancies has improved significantly with the utilization of highly active antiretroviral...
Azathioprine, adverse reactions - seriousCyclophosphamide, adverse reactions - seriousImmunosuppressants, adverse reactions - seriousMycophenolate-mofetil, adverse reactions - seriousNon-Hodgkin's-lymphoma, drug-inducedPrednisone, adverse reactions - serious...
The treatment of Hodgkin lymphoma has improved dramatically over the last 20 years, with advances in imaging techniques. In the early stages, this cancer of the immune system can be cured with a 95 percent success rate by a combination of radiation and chemotherapy. The major challenge is ...
BACKGROUND: Non-Hodgkin lymphoma (NHL) is the most common hematologic malignant neoplasm in adults. We use the novel technique of period analysis to disclo... LG Maharam,SJ Mcliveen,JM Hagberg,... - 《Medicine & Science in Sports & Exercise》 被引量: 0发表: 1995年 The legend grows Dis...
Primary cardiac lymphoma is a very rare malignancy, which is typically of a non-Hodgkin type, and involves only the heart and pericardium with no or minima... RM Gowda,IA Khan - 《Angiology》 被引量: 204发表: 2003年 Evaluation of Late Cardiotoxicity by Pulsed Doppler Echocardiography in Pati...
Iodine-131-tositumomab, therapeutic useNon-Hodgkin's-lymphoma, treatment
In recent times our knowledge of the biology of the Immune system has clarified the origin of subsets of lymphomas and provided specific targets of future therapeutic approaches.The lymphomasLymphoma, Non-Hodgkin
Bendamustine, therapeutic useNon-Hodgkin's-lymphoma, treatment
Lymphoma, treatmentRituximab, therapeutic use